Table 2.
Participants in the exploratory study.
| Scale variables | Total | Group A–Exo | Group B–Nxo | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| Age (years) | 69.2 | 6.7 | 67.6 | 5.9 | 70.7 | 7.3 |
| Weight (kg) | 74.0 | 18.2 | 71.4 | 18.4 | 76.4 | 18.4 |
| Height (cm) | 166.4 | 8.4 | 165.4 | 9.3 | 167.4 | 7.7 |
| BMI (kg*m−2) | 26.6 | 5.8 | 26.0 | 5.8 | 27.2 | 5.9 |
| MoCA | 24.2 | 3.5 | 25.2 | 3.2 | 23.2 | 3.6 |
| Cat. variables | Count | % | Count | % | Count | % |
|---|---|---|---|---|---|---|
| Sex | ||||||
| Male | 11 | 40.7 | 4 | 30.8 | 7 | 50.0 |
| Female | 16 | 59.3 | 9 | 69.2 | 7 | 50.0 |
| H&Y | ||||||
| Stage I | 11 | 40.7 | 4 | 30.8 | 7 | 50.0 |
| Stage II | 8 | 29.6 | 4 | 30.8 | 4 | 28.6 |
| Stage III | 7 | 25.9 | 5 | 38.5 | 2 | 14.3 |
| Stage IV | 1 | 3.7 | 0 | 0.0 | 1 | 7.1 |
Exo Exoskeleton exercise training, Nxo Exercise training without exoskeleton, BMI Body mass index, MoCA Montreal Cognitive Assessment, H&Y Hoehn & Yahr PD disease stage.